Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Align Technology Ongoing Support of Orthodontic and Dental Research

Align Technology,Inc.
Posted on: 01 Nov 17

2018 Grant Application Process Now Open for up to $300,000 in Funding

SAN JOSE, CA--(Marketwired - November 01, 2017) - Align Technology, Inc. (NASDAQ:  ALGN ) today announced the opening of its 2018 Research Award Program to support clinical and scientific dental research in universities across the globe. This year, up to $300,000 will be awarded to university faculty for scientific and technological research initiatives to advance patient care in the fields of orthodontics and dentistry.

"Through our Research Award Program, Align Technology has funded over $1.7 million in research awards since its inception in 2010 providing insights which include tooth movement efficacy with clear aligner therapy, oral hygiene and microbial bacteria presence or absence with clear aligners, and comparisons in quality of life with aligners as compared to fixed appliances. For example, treatment with Invisalign clear aligners finished 5 months faster on average than treatment with braces* based on the awarded research," said Zelko Relic, Align Technology vice president research and development. "We are honored to enable the research in orthodontics and dentistry with a goal to improve orthodontic and dental treatment for communities around the globe."

Awards available for 2018 are four one-year awards of up to $25,000 each for dental research at universities in North America and eight one-year awards of up to $25,000 each for dental research at International universities.

Eligible applicants for the dental research award component include full- and part-time faculty involved in dental or scientific research at universities at which Invisalign® treatment is available. All applications are reviewed by an independent academic committee that forwards its recommendations to Align Technology for final selection. Program details, instructions, and application forms for prospective applicants can be found at  https://learn.invisalign.com/researchawards  (for North American applicants) and  https://learn.invisalign.com/internationalresearch  (for International applicants). Research proposals and completed applications must be received by 5:00 p.m. Pacific Standard Time on March 2, 2018. Award recipients will be notified by June 1, 2018.

* Data on file with Align Technology

About Align Technology, Inc.
Align Technology designs and manufactures the Invisalign® system, the most advanced clear aligner system in the world, and iTero® intraoral scanners and services. Align's products help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients. Visit  www.aligntech.com  for more information.

For additional information about the Invisalign system or to find an Invisalign provider in your area, please visit  www.invisalign.com . For additional information about iTero digital scanning system, please visit  www.itero.com .

Contact Information

Align Technology:
Yin Cantor 
(408) 470-1044
ycantor@aligntech.com

Ethos Communication:
Shannon Mangum Henderson
(678) 261-7803
align@ethoscommunication.com



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Align Technology, Inc. via GlobeNewswire
HUG#2146322
GlobeNewswire
globenewswire.com

Last updated on: 02/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.